CRP and COVID-19: This cytokine release syndrome may contribute to many of the clinical and laboratory findings reported in severe COVID-19: cytopenias, coagulopathy, hyperferritinemia and other acute-phase reactants (e.g., CRP, D-dimer) increase, endothelial damage and vascular permeability.